comparemela.com

Latest Breaking News On - New therapeutic - Page 1 : comparemela.com

ASSURE: Seladelpar Achieves Clinical Improvement in Primary Biliary Cholangitis

Interim results from the open-label, phase 3 study show seladelpar demonstrated clinically meaningful improvements in markers of cholestasis and liver injury.

Molecular Partners Presents New Data on its Radio DARPin Therapy (RDT) Platform at the EANM

New preclinical RDT data show that DARPins can be engineered to increase tumor uptake as well as reducing accumulation in kidneysEngineering solutions transferrable across the platform and to a broad

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.